Beta Bionics BBNX
NASDAQ BBNX
$17.42 -1.91 (-9.88%)
As of: Sep 9, 2026 · 3:59 PM EDT

Beta Bionics (BBNX) EBITDA Margin Growth (1y) (2025 - 2026)

Analysis

Beta Bionics (BBNX) EBITDA Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -497.00
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 314.00
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 124.00
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 670.00
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 546.00
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 264.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -919.00
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 595.00
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 146.00
10 Beta Bionics 786.45 Mn 605.96 Mn 18.90 Mn 562.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 562.00
Mar 31, 2026 1,783.00
Dec 31, 2025 1,358.00
Sep 30, 2025 317.00
Jun 30, 2025 -720.00
Mar 31, 2025 -3,259.00